Literature DB >> 24001045

Whole-blood cultures from patients with chronic periodontitis respond differently to Porphyromonas gingivalis but not Escherichia coli lipopolysaccharide.

Getulio Nogueira-Filho1, Bruno Trevisan Rosa, Patricia Ferreira Santos, Urbino Rocha Tunes, Songeli Menezes Freire, Roberto Meyer, Richard P Darveau.   

Abstract

BACKGROUND: Porphyromonas gingivalis lipid A heterogeneity modulates cytokine expression in human cells. This study investigates the effects of two lipid A isoforms of P. gingivalis, lipopolysaccharide (LPS)1435/1449 and LPS1690, on the secretion of proinflammatory and regulatory cytokines in total blood cultures from patients with and without chronic periodontitis (CP).
METHODS: A cross-sectional study was conducted in 38 systemically healthy individuals divided in two groups: 1) the CP group (n = 19), in which patients were diagnosed with CP; and 2) the no periodontitis (NP) group (n = 19), which included control patients without CP. Blood samples were collected from all patients, and whole-blood cell cultures (WBCCs) were stimulated for 48 hours with P. gingivalis LPS1435/1449 and LPS1690 and Escherichia coli LPS. Unstimulated WBCCs served as negative controls. The secretion of interferon-γ (IFN-γ), interleukin-10 (IL-10), and transforming growth factor-β (TGF-β) was detected in WBCC supernatants by enzyme-linked immunosorbent assays.
RESULTS: E. coli LPS significantly increased the expression of all cytokines in WBCCs from both the NP and CP groups when compared to non-stimulated cells (control treatment). P. gingivalis LPS preparations increased IFN-γ levels in the CP group but not in the NP group when compared with controls (P <0.05). P. gingivalis LPS preparations also increased IL-10 and TGF-β levels in both CP and NP groups, but P. gingivalis LPS1690 showed a three-fold increase on IL-10 production in the NP group (P <0.05) when compared to P. gingivalis LPS1435/144.
CONCLUSIONS: These data demonstrate that WBCC cell populations obtained from healthy individuals and patients with CP may differ in the cytokine response to P. gingivalis but not E. coli LPS. This is consistent with the notion that CP alters the systemic WBCC response and that this can be detected by the different P. gingivalis LPS structures.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24001045     DOI: 10.1902/jop.2013.120735

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  5 in total

1.  Low-intensity pulsed ultrasound upregulates osteogenesis under inflammatory conditions in periodontal ligament stem cells through unfolded protein response.

Authors:  Han Li; Yuejia Deng; Minmin Tan; Ge Feng; Yunchun Kuang; Jie Li; Jinlin Song
Journal:  Stem Cell Res Ther       Date:  2020-06-03       Impact factor: 6.832

2.  Application of the In Vitro HoxB8 Model System to Characterize the Contributions of Neutrophil-LPS Interaction to Periodontal Disease.

Authors:  Maja Sochalska; Magdalena B Stańczyk; Maria Użarowska; Natalia Zubrzycka; Susanne Kirschnek; Aleksander M Grabiec; Tomasz Kantyka; Jan Potempa
Journal:  Pathogens       Date:  2020-07-01

3.  Lipoteichoic acid (LTA) and lipopolysaccharides (LPS) from periodontal pathogenic bacteria facilitate oncogenic herpesvirus infection within primary oral cells.

Authors:  Lu Dai; Michael R DeFee; Yueyu Cao; Jiling Wen; Xiaofei Wen; Mairi C Noverr; Zhiqiang Qin
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

4.  Effect of Allium cepa L. on Lipopolysaccharide-Stimulated Osteoclast Precursor Cell Viability, Count, and Morphology Using 4',6-Diamidino-2-phenylindole-Staining.

Authors:  Tatiane Oliveira; Camila A Figueiredo; Carlos Brito; Alexander Stavroullakis; Anuradha Prakki; Eudes Da Silva Velozo; Getulio Nogueira-Filho
Journal:  Int J Cell Biol       Date:  2014-08-03

Review 5.  Pathogenesis of Important Virulence Factors of Porphyromonas gingivalis via Toll-Like Receptors.

Authors:  Lu Jia; Nannan Han; Juan Du; Lijia Guo; Zhenhua Luo; Yi Liu
Journal:  Front Cell Infect Microbiol       Date:  2019-07-18       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.